EE200200317A - Sahhariini derivaadid kui peroraalselt toimivad elastaasi inhibiitorid - Google Patents
Sahhariini derivaadid kui peroraalselt toimivad elastaasi inhibiitoridInfo
- Publication number
- EE200200317A EE200200317A EEP200200317A EEP200200317A EE200200317A EE 200200317 A EE200200317 A EE 200200317A EE P200200317 A EEP200200317 A EE P200200317A EE P200200317 A EEP200200317 A EE P200200317A EE 200200317 A EE200200317 A EE 200200317A
- Authority
- EE
- Estonia
- Prior art keywords
- orally active
- elastase inhibitors
- saccharin derivatives
- active elastase
- saccharin
- Prior art date
Links
- 239000003602 elastase inhibitor Substances 0.000 title 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9904624A HUP9904624A2 (hu) | 1999-12-17 | 1999-12-17 | Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik |
| PCT/HU2000/000130 WO2001044245A1 (en) | 1999-12-17 | 2000-12-14 | Saccharin derivatives as orally active elastase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200317A true EE200200317A (et) | 2003-06-16 |
Family
ID=49322887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200317A EE200200317A (et) | 1999-12-17 | 2000-12-14 | Sahhariini derivaadid kui peroraalselt toimivad elastaasi inhibiitorid |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20030114449A1 (cs) |
| EP (1) | EP1255756A1 (cs) |
| JP (1) | JP2003516990A (cs) |
| KR (1) | KR20030022769A (cs) |
| CN (1) | CN1411458A (cs) |
| AR (1) | AR035389A1 (cs) |
| AU (1) | AU2210501A (cs) |
| BG (1) | BG106811A (cs) |
| BR (1) | BR0016364A (cs) |
| CA (1) | CA2395486A1 (cs) |
| CZ (1) | CZ20022016A3 (cs) |
| EE (1) | EE200200317A (cs) |
| HU (1) | HUP9904624A2 (cs) |
| IL (1) | IL149864A0 (cs) |
| IS (1) | IS6418A (cs) |
| NO (1) | NO20022838L (cs) |
| PL (1) | PL355316A1 (cs) |
| RU (1) | RU2002119007A (cs) |
| WO (1) | WO2001044245A1 (cs) |
| ZA (1) | ZA200204604B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| EP1474151A4 (en) * | 2002-01-17 | 2010-03-03 | R E D Lab N V | METHODS OF TREATING CHRONIC IMMUNE DISEASE |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
-
1999
- 1999-12-17 HU HU9904624A patent/HUP9904624A2/hu unknown
-
2000
- 2000-12-14 PL PL00355316A patent/PL355316A1/xx not_active Application Discontinuation
- 2000-12-14 AU AU22105/01A patent/AU2210501A/en not_active Abandoned
- 2000-12-14 JP JP2001544735A patent/JP2003516990A/ja not_active Withdrawn
- 2000-12-14 EE EEP200200317A patent/EE200200317A/xx unknown
- 2000-12-14 WO PCT/HU2000/000130 patent/WO2001044245A1/en not_active Application Discontinuation
- 2000-12-14 CN CN00817305A patent/CN1411458A/zh active Pending
- 2000-12-14 CZ CZ20022016A patent/CZ20022016A3/cs unknown
- 2000-12-14 CA CA002395486A patent/CA2395486A1/en not_active Abandoned
- 2000-12-14 RU RU2002119007/04A patent/RU2002119007A/ru unknown
- 2000-12-14 US US10/149,569 patent/US20030114449A1/en not_active Abandoned
- 2000-12-14 BR BR0016364-3A patent/BR0016364A/pt not_active Application Discontinuation
- 2000-12-14 IL IL14986400A patent/IL149864A0/xx unknown
- 2000-12-14 EP EP00985705A patent/EP1255756A1/en not_active Withdrawn
- 2000-12-14 KR KR1020027007684A patent/KR20030022769A/ko not_active Withdrawn
- 2000-12-18 AR ARP000106721A patent/AR035389A1/es unknown
-
2002
- 2002-06-07 ZA ZA200204604A patent/ZA200204604B/xx unknown
- 2002-06-11 BG BG106811A patent/BG106811A/bg unknown
- 2002-06-12 IS IS6418A patent/IS6418A/is unknown
- 2002-06-14 NO NO20022838A patent/NO20022838L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20030114449A1 (en) | 2003-06-19 |
| ZA200204604B (en) | 2004-04-28 |
| AR035389A1 (es) | 2004-05-26 |
| IS6418A (is) | 2002-06-12 |
| NO20022838D0 (no) | 2002-06-14 |
| HUP9904624A2 (hu) | 2002-01-28 |
| WO2001044245A1 (en) | 2001-06-21 |
| CN1411458A (zh) | 2003-04-16 |
| JP2003516990A (ja) | 2003-05-20 |
| BG106811A (bg) | 2002-12-29 |
| BR0016364A (pt) | 2002-09-10 |
| CZ20022016A3 (cs) | 2003-04-16 |
| HUP9904624D0 (en) | 2000-02-28 |
| CA2395486A1 (en) | 2001-06-21 |
| EP1255756A1 (en) | 2002-11-13 |
| RU2002119007A (ru) | 2004-01-10 |
| NO20022838L (no) | 2002-06-14 |
| PL355316A1 (en) | 2004-04-19 |
| IL149864A0 (en) | 2002-11-10 |
| KR20030022769A (ko) | 2003-03-17 |
| AU2210501A (en) | 2001-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1220856E (pt) | Compostos farmaceuticamente activos | |
| NO20015664L (no) | Nye farmasöytisk aktive forbindelser | |
| DK1218374T3 (da) | Farmaceutisk aktive sulfonamidderivater | |
| EE05330B1 (et) | Kinasoliini derivaadid kui VEGF-i inhibiitorid | |
| NO20020222L (no) | Oralt aktive androgener | |
| CY2016002I1 (el) | Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου | |
| EE200200140A (et) | Pteridinoonid kui kinaasi inhibiitorid | |
| NO20013559D0 (no) | Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler | |
| EE200300015A (et) | Kolhinooli derivaadid kui angiogeneesi inhibiitorid | |
| DK1198453T3 (da) | N-(indolcarbonyl-)piperazinderivater | |
| PT1175408E (pt) | Derivados sulfonamida | |
| DK1237857T3 (da) | Nye Phenalkyloxyphenylderivater | |
| DE60043730D1 (de) | Arylsulfonamid-substituierte hydroxamsäure-derivate | |
| EE200200555A (et) | Farmatseutiliselt aktiivsed pürrolidiini derivaadid | |
| EE200100039A (et) | Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid | |
| NO20023001D0 (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
| EE200200317A (et) | Sahhariini derivaadid kui peroraalselt toimivad elastaasi inhibiitorid | |
| EE200100381A (et) | Morfolinobensamiidi uued soolad | |
| NO20022682L (no) | Heterosykliske derivater | |
| ITMI991742A0 (it) | Bisplatino complessi attivi per via orale | |
| DK1183236T3 (da) | Cinnamoylaminoalkylsubstituerede benzensulfonamidderivater | |
| SE9901854D0 (sv) | New pharmaceutically active compounds | |
| SE9802539D0 (sv) | New pharmaceutically active compounds | |
| FI20000395A7 (fi) | N-(amidinobentsoyyli- tai amidinopyridyylikarbonyyli)-alfa-aminohappojohdannaisia |